Navigation Links
Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
Date:1/17/2013

cknewsnow.com/">www.stocknewsnow.com financial portal, the Ask Mr. Wallstreet newsletter, www.SNNwire.com & the Patent Pending, SNN Video Press Release, VPR™. SNN owns and operates the SNNLive TV show & the SNN StockUmentary TV show, and StockNewsNow Radio with Gary McKenzie .  StockNewsNow.com is a Micro-Cap financial portal that features SNNLive CEO Video Interviews, the Micro-Cap Review Magazine, S&P Capital IQ Stock Reports, StockNewsNow Radio, Wall Street Views, and Real-Time News from the financial markets.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One focuses on modification of peptides with Ii-Key to increase potency while a second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website a
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
2. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
3. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
4. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
5. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
6. Exon skipping to restore gene expression is promising therapeutic strategy for muscular dystrophy
7. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
8. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
9. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
10. Breast cancer cells growing in 3D-matrix revert to normal
11. First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Pressure BioSciences, Inc. ... the Company will host a teleconference to discuss its ... business update. The teleconference information is provided below: ... Eastern Daylight Time (EDT) Dial-in: (800) 875-3456 ... 607-2001 (Int,l) Passcode: VS22823 For those unable ...
(Date:5/23/2013)... 23, 2013 African Ancestry ... for people of African descent, today announced new ... For people of all races, myDNAmix determines various ... distinct populations: Indigenous Americas (Native American), East Asia, ... , Originally launched in late 2011, ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Just released this ... executive coach and author Barbara Roche: “Commit to Confidence: ... , Filled with helpful tips and quotes from the fields ... leaders, and tangible exercises that readers can do on their ... to achieve their personal and professional goals. , ...
(Date:5/22/2013)... The Conference Forum announced the ... Clinical Trials conference taking place on September 19-20 at ... , Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, ... to reduce expensive infrastructure, engage patients and generate credible ... big, or novel, or it must change the very ...
Breaking Biology Technology:Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2
... Opportunity Exists for Development of More Effective Therapies That, ... from Decision Resources, WALTHAM, Mass., Sept. 26 ... firms for pharmaceutical and,healthcare issues, finds that the emergence ... will be the key factor driving the,pancreatic cancer drug ...
... Sept. 26 Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ... Chairman, will provide a corporate presentation at the,Natixis ... on October 8,2007 at 8:00 a.m. Eastern time. ... be accessed by visiting the,Investors section of the ...
... Phil Coggins to Continue as President and CSO, ... Osprey,Pharmaceuticals, Ltd., a privately held biotechnology company developing,first-in-class ... today the appointment of Jack M. Anthony to ... the position of,CEO will continue as President and ...
Cached Biology Technology:Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016 2Osprey Pharmaceuticals Names Jack M. Anthony as CEO 2Osprey Pharmaceuticals Names Jack M. Anthony as CEO 3
(Date:5/23/2013)... honored more than 165 staff for their creation, ... annual Intellectual Property Commercialization Recognition & Rewards Program ... laboratory named materials scientist Jun Liu Inventor of ... that can store large amounts of energy, ease ... time it takes to charge cell phones, electric ...
(Date:5/23/2013)... the new mechanism by which estrogen suppresses lipid synthesis ... potential new approach toward treating certain liver diseases. ... believe they are changing long-held views in the field. ... the journal Science Signaling . , "The dogma ... been that only receptors located in the nucleus respond ...
(Date:5/23/2013)... cancer patients unnecessarily undergo surgery or harsh treatments ... slow-growing and aggressive forms of the disease. Researchers ... Medical Institutes are developing technology that allows patients ... relatively mild treatments or take drastic measures. , ... an associate professor of biomedical engineering at Case ...
Breaking Biology News(10 mins):PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... release is available in Spanish . ... hardening of the arteries, according to results of a ... mice. The research provides the first direct evidence that ... of atherosclerosis, from increasing in size in arteries. ...
... , DALLAS Sept. 29, 2010 More people ... UT Southwestern Medical Center analysis of national alcohol consumption ... suggests that a variety of factors, including social, economic ... increase. "The reasons for the uptick vary and ...
... linger on the shores of Alaska,s Prince William Sound ... despite almost 20 years of weathering and decomposition, scientists ... appear in ACS, semi-monthly journal Environmental Science & ... up remaining traces of the Exxon Valdez spill ...
Cached Biology News:Blueberries help fight artery hardening, lab animal study indicates 2Alcohol consumers are becoming the norm, UT Southwestern analysis finds 2Alcohol consumers are becoming the norm, UT Southwestern analysis finds 3Simple approach could clean up oil remaining from Exxon Valdez spill 2
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
... an early protein. Can ... post-infection exhibiting an intranuclear inclusion ... between 6-24 hours. These ... granular staining. No other ...
... α, clone 8G8/5 GenBank Accession Number ... human AP-2alpha/gamma fusion protein corresponding to residues ... of human AP-2γ Formulation: 0.1M Tris-glycine, pH ... the addition of glycerol to 30% Quality ...
Parathyroid Hormone Receptor 2 [PTHR2]...
Biology Products: